Target Price | €32.47 |
Price | €27.93 |
Potential | 16.28% |
Number of Estimates | 17 |
17 Analysts have issued a price target Bayer 2025 . The average Bayer target price is €32.47. This is 16.28% higher than the current stock price. The highest price target is €61.00 118.44% , the lowest is €26.00 6.89% . | |
A rating was issued by 18 analysts: 3 Analysts recommend Bayer to buy, 15 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Bayer stock has an average upside potential 2025 of 16.28% . Most analysts recommend the Bayer stock at Hold. |
15 Analysts have issued a sales forecast Bayer 2024 . The average Bayer sales estimate is €46.9b . This is 0.41% lower than the revenue of the last 12 months(TTM). The highest sales forecast is €48.1b 2.12% , the lowest is €45.6b 3.32% .
This results in the following potential growth metrics:
2023 | €47.6b | 6.11% |
---|---|---|
2024 | €46.9b | 1.50% |
2025 | €47.8b | 1.81% |
2026 | €48.6b | 1.74% |
2027 | €49.2b | 1.27% |
2028 | €50.1b | 1.85% |
15 Analysts have issued an Bayer EBITDA forecast 2024. The average Bayer EBITDA estimate is €10.4b . This is 11.49% lower than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is €10.9b 7.39% , the lowest is €9.9b 15.38% .
This results in the following potential growth metrics and future EBITDA Margins:
2023 | €12.3b | 1.26% |
---|---|---|
2024 | €10.4b | 15.74% |
2025 | €10.8b | 3.80% |
2026 | €11.0b | 2.20% |
2027 | €11.1b | 0.42% |
2028 | €11.8b | 6.67% |
2023 | 25.91% | 7.86% |
---|---|---|
2024 | 22.16% | 14.47% |
2025 | 22.60% | 1.99% |
2026 | 22.70% | 0.44% |
2027 | 22.51% | 0.84% |
2028 | 23.58% | 4.75% |
9 Bayer Analysts have issued a net profit forecast 2024. The average Bayer net profit estimate is €2.4b . This is 288.48% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is €4.3b 437.21% , the lowest is €1.5b 217.83% .
This results in the following potential growth metrics and future Net Margins:
2023 | €-2.9b | 170.85% |
---|---|---|
2024 | €2.4b | 181.32% |
2025 | €3.2b | 33.48% |
2026 | €3.5b | 9.96% |
2027 | €3.7b | 6.27% |
2028 | €4.2b | 12.57% |
2023 | -6.17% | 175.47% |
---|---|---|
2024 | 5.09% | 182.55% |
2025 | 6.67% | 31.04% |
2026 | 7.21% | 8.10% |
2027 | 7.57% | 4.99% |
2028 | 8.37% | 10.57% |
9 Analysts have issued a Bayer forecast for earnings per share. The average Bayer <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is €2.43 . This is 288.37% higher than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is €4.35 437.21% , the lowest is €1.52 217.83% .
This results in the following potential growth metrics and future valuations:
2023 | €-2.99 | 170.85% |
---|---|---|
2024 | €2.43 | 181.27% |
2025 | €3.25 | 33.74% |
2026 | €3.57 | 9.85% |
2027 | €3.79 | 6.16% |
2028 | €4.27 | 12.66% |
Current | -21.67 | 175.93% |
---|---|---|
2024 | 11.30 | 153.03% |
2025 | 8.46 | 25.13% |
2026 | 7.70 | 8.98% |
2027 | 7.24 | 5.97% |
2028 | 6.43 | 11.19% |
Based on analysts' sales estimates for 2024, the Bayer stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 1.49 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 0.58 .
This results in the following potential growth metrics and future valuations:
Current | 1.49 | 19.89% |
---|---|---|
2024 | 1.49 | 0.56% |
2025 | 1.46 | 1.77% |
2026 | 1.44 | 1.70% |
2027 | 1.42 | 1.25% |
2028 | 1.39 | 1.82% |
Current | 0.58 | 41.55% |
---|---|---|
2024 | 0.58 | 0.42% |
2025 | 0.56 | 1.77% |
2026 | 0.56 | 1.72% |
2027 | 0.55 | 1.24% |
2028 | 0.54 | 1.82% |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.